Blueshift Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Buy
+1,357
New +$281K 0.06% 413
2025
Q4
– Sell
-909
Closed -$249K – 630
2025
Q3
$249K Buy
+909
New +$248K 0.08% 351
2024
Q2
– Sell
-2,095
Closed -$415K – 415
2024
Q1
$415K Sell
2,095
-2,726
-57% -$500K 0.22% 148
2023
Q4
$829K Buy
4,821
+1,019
+27% +$157K 0.44% 59
2023
Q3
$562K Buy
3,802
+519
+16% +$93.8K 0.33% 88
2023
Q2
$717K Sell
3,283
-676
-17% -$151K 0.27% 93
2023
Q1
$867K Sell
3,959
-1,092
-22% -$237K 0.36% 76
2022
Q4
$1.05M Buy
5,051
+753
+18% +$165K 0.49% 49
2022
Q3
$938K Sell
4,298
-4,554
-51% -$1.04M 0.2% 142
2022
Q2
$1.86M Buy
8,852
+6,622
+297% +$1.41M 0.31% 80
2022
Q1
$541K Sell
2,230
-3,564
-62% -$862K 0.05% 415
2021
Q4
$1.51M Sell
5,794
-169
-3% -$43.9K 0.13% 209
2021
Q3
$1.57M Sell
5,963
-13,298
-69% -$3.64M 0.09% 293
2021
Q2
$4.75M Buy
+19,261
New +$4.05M 0.26% 105
2020
Q3
– Sell
-5,241
Closed -$1.01M – 751
2020
Q2
$1.01M Buy
+5,241
New +$857K 0.16% 181
2020
Q1
– Sell
-5,751
Closed -$891K – 589
2019
Q4
$891K Buy
5,751
+397
+7% +$57.2K 0.1% 307
2019
Q3
$723K Buy
5,354
+2,669
+99% +$350K 0.11% 268
2019
Q2
$328K Sell
2,685
-545
-17% -$60.4K 0.04% 511
2019
Q1
$336K Sell
3,230
-9,600
-75% -$991K 0.05% 502
2018
Q4
$1.46M Buy
+12,830
New +$1.37M 0.27% 85

Other funds holding RMD

Blueshift Asset Management's RMD Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in ResMed (RMD) in Q2 2026: 1,357 shares worth $264K. The stake represents 0.06% of the portfolio and ranks #413 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in RMD as recently as Q3 2025.

Blueshift Asset Management first reported a position in RMD in Q4 2018 and has held it in 20 quarters since. The position peaked at $4.75M in Q2 2021. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Blueshift Asset Management held 1,357 shares of ResMed worth $264K as of Q2 2026.
  • ResMed was a new Blueshift Asset Management position in Q2 2026.
  • ResMed made up 0.06% of Blueshift Asset Management's portfolio in Q2 2026, its #413 holding.
  • Blueshift Asset Management first reported a position in ResMed in Q4 2018 and has held it in 20 quarters since.
  • Blueshift Asset Management's ResMed position peaked at $4.75M in Q2 2021.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.